Alcon has acquired a majority interest in Aurion Biotech, according to a press release. Aurion will operate as a separate ...

Eye care giant Alcon appears to have gained the upper hand in the ongoing power struggle with Aurion Biotech by securing a ...

The corneal endothelium showed a beaten bronze appearance without corneal edema (Figure 1b). The left fundus showed significant retinal venous tortuosity with an otherwise normal retina and a ...

According to experts, corneal ulcers are common among contact ... Thereafter her eyes experienced swelling and became watery as well. Lillie said the next day, she visited a chemist who gave ...

Alcon Acquires Majority Interest in Aurion Biotech, Inc. to Advance Innovative Cell Therapy for Corneal Endothelial Disease ...

Aurion is developing AURN001, a clinical-stage allogeneic cell therapy asset, for corneal edema secondary to corneal ...

Aurion will operate as a separate company with full support from Alcon to advance its clinical-stage allogeneic cell therapy asset, AURN001, into Phase 3 for corneal edema secondary to corneal ...

GENEVA, March 26, 2025--(BUSINESS WIRE)--Regulatory News: Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced it has acquired a ...